3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here or
3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here or
Advertisement
3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here or
SCNI Scinai Immunotherapeutics Ltd.
4,726
$3.62
$0.17
(4.93%)
| Watchers | 4,726 |
| 52-Wk Low | $3.20 |
| 52-Wk High | $18.70 |
| Market Cap | $1.68M |
| Volume | 11.00 |
| 52-Wk High | $18.70 |
| 52-Wk Low | $3.20 |
Scinai Immunotherapeutics Announces Receipt of a Nasdaq Staff Determination Letter Regarding Shareholders' Equity listing requirements and Hearing to Present a Plan for Regaining CompliancePR Newswire • 13 days ago
Scinai Immunotherapeutics Announces Receipt of a Nasdaq Staff Determination Letter Regarding Shareholders' Equity listing requirements and Hearing to Present a Plan for Regaining Compliance Scinai...
Share to Feed
Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides Business Update Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and...
Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal PR Newswire JERUSALEM...
Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schn of UMG Scinai to showcase its novel biological...
Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing Services Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug...
Scinai leadership to attend BIO-Europe Spring 2024 Scinai leadership to attend BIO-Europe Spring 2024 PR Newswire JERUSALEM, March 12, 2024 Showcasing Company's cGMP biologics CDMO and innovative...
Scinai to showcase its cGMP biologics CDMO and innovative NanoAb pipeline at MIXiii 2024 Scinai to showcase its cGMP biologics CDMO and innovative NanoAb pipeline at MIXiii 2024 PR Newswire...
Scinai Welcomes Liat Halpert as Head of Business Development and Sales Scinai Welcomes Liat Halpert as Head of Business Development and Sales PR Newswire JERUSALEM, Feb. 13, 2024 JERUSALEM, Feb. 13...
Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research Collaborator Dirk Grlich on Louis-Jeantet Prize Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...